NCT05210634View on ClinicalTrials.gov

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CHI-915 in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

January 11, 2022

Primary Completion Date

May 6, 2022

Study Completion Date

May 6, 2022

Conditions

Healthy Adults

Interventions

DIETARY_SUPPLEMENT

THCv

THCv in MCT oil

Trial Locations (1)

55114

Nucleus Network, Saint Paul

All Listed Sponsors

lead

Canopy Growth Corporation

INDUSTRY